Beam reports breakthrough results from BEAM-101's early-stage trial for severe sickle cell disease. Read more here.

Studies doing genome-wide testing can easily ID patients with naturally low neutrophil counts, but nobody's looking at it, ...

Indian American immunologist selected as next Chair of University of Rochester Medical Center Department of Microbiology and Immunology ...

Scientists have discovered that certain immune cells—called neutrophils—can start making a protein called DUOX2 that they ...

Scientists have discovered that certain immune cells — called neutrophils — can start making a protein called DUOX2 that they ...

Study met primary endpoint of safety and tolerability at all doses and secondary pharmacodynamic and pharmacokinetic ...

New research reveals a surprising twist: how cells meant to protect us may be making things worse in gut diseases like ...

The drug Mavorixafor was previously granted the Fast Track designation for the treatment of WHIM syndrome, a rare immunodeficiency indication for which it received FDA approval in April 2024, X4 said.

X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, ...

A digestive system specialist has said that you're probably eating fruit wrong - and if so, you may want to change what you're doing now. According to @dramariamunoz, you need to stop peeling parts of ...

Tel Aviv University researchers say neutrophils can be late-stage breast cancer target and biomarker; Beilinson Hospital ...

Immune cells known as neutrophils act as first responders to infection. Research on zebrafish shows light regulates their activity and boosts their ability to kill bacteria.